{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:17:35Z","timestamp":1792603055046,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Currently, serodiagnosis of infection with the helminth parasite<jats:italic>Onchocerca volvulus<\/jats:italic>is limited to the Ov-16 IgG4 test, a test that has limited sensitivity and suboptimal specificity. In previous studies, we identified several linear epitopes that have the potential to supplement the diagnostic toolbox for onchocerciasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In this study three peptides, bearing in total six linear epitopes were transferred to a multiplex ELISA platform. This multiplex ELISA was used to assess the clinical utility of the peptide serology markers by analyzing sample sets from both<jats:italic>O. volvulus<\/jats:italic>endemic and non-endemic regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The multiplex platform was shown to be reproducible and data obtained on the multiplex platform were comparable to the singleplex ELISA data. The clinical utility assessment showed that in a population of school-aged children from western Kenya, a virtually<jats:italic>O. volvulus<\/jats:italic>-free area, significant cross-reactivity with an as-yet to be determined immunogen was detected.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The observations made in this study invalidate the usefulness of the peptide serology markers for onchocerciasis detection. We discuss what could be the origin of this unexpected serological response, but also highlight the need for better characterized biobanks for biomarker discovery activities.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13071-019-3824-x","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T16:02:48Z","timestamp":1575043368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Assessment of multiplex Onchocerca volvulus peptide ELISA in non-endemic tropical regions"],"prefix":"10.1186","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-1313","authenticated-orcid":false,"given":"Ole","family":"Lagatie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Granjon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice R.","family":"Odiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maan","family":"Zrein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven J.","family":"Stuyver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"3824_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/S0140-6736(14)60875-8","volume":"383","author":"P Holmes","year":"2014","unstructured":"Holmes P, on behalf of the WHO Strategic and Advisory Group on Neglected Tropical Diseases. Neglected tropical diseases in the post-2015 health agenda. Lancet. 2014;383:1803.","journal-title":"Lancet."},{"key":"3824_CR2","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1172\/JCI34261","volume":"118","author":"PJ Hotez","year":"2008","unstructured":"Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, Jacobson J. Helminth infections: the great neglected tropical diseases. J Clin Invest. 2008;118:1311\u201321.","journal-title":"J Clin Invest."},{"key":"3824_CR3","first-page":"633","volume-title":"Releve epidemiologique hebdomadaire\/Section d\u02bchygiene du Secretariat de la Societe des Nations = Weekly epidemiological record\/Health Section of the Secretariat of the League of Nations","author":"WHO","year":"2018","unstructured":"WHO. Progress report on the elimination of human onchocerciasis, 2017\u20132018. In: Cantey P, editor. Releve epidemiologique hebdomadaire\/Section d\u02bchygiene du Secretariat de la Societe des Nations = Weekly epidemiological record\/Health Section of the Secretariat of the League of Nations, vol. 93. Geneva: World Health Organization; 2018. p. 633\u201348."},{"key":"3824_CR4","first-page":"297","volume":"72","author":"LH Borup","year":"2003","unstructured":"Borup LH, Peters JS, Sartori CR. Onchocerciasis (river blindness). Cutis. 2003;72:297\u2013302.","journal-title":"Cutis."},{"key":"3824_CR5","doi-asserted-by":"publisher","first-page":"10795","DOI":"10.1158\/0008-5472.CAN-06-0755","volume":"66","author":"C Denkert","year":"2006","unstructured":"Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J, et al. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 2006;66:10795\u2013804.","journal-title":"Cancer Res."},{"key":"3824_CR6","doi-asserted-by":"publisher","first-page":"467","DOI":"10.4269\/ajtmh.1989.41.467","volume":"41","author":"HR Taylor","year":"1989","unstructured":"Taylor HR, Munoz B, Keyvan-Larijani E, Greene BM. Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Am J Trop Med Hyg. 1989;41:467\u201371.","journal-title":"Am J Trop Med Hyg."},{"key":"3824_CR7","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.pt.2015.06.007","volume":"31","author":"J Vlaminck","year":"2015","unstructured":"Vlaminck J, Fischer PU, Weil GJ. Diagnostic tools for onchocerciasis elimination programs. Trends Parasitol. 2015;31:571\u201382.","journal-title":"Trends Parasitol."},{"key":"3824_CR8","unstructured":"WHO. Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: Criteria and procedures. In: WHO Guidelines Approved by the Guidelines Review Committee. Geneva: World Health Organization; 2016."},{"key":"3824_CR9","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1128\/CVI.00227-15","volume":"22","author":"C Steel","year":"2015","unstructured":"Steel C, Golden A, Stevens E, Yokobe L, Domingo GJ, de los Santos T, et al. Rapid point-of-contact tool for mapping and integrated surveillance of Wuchereria bancrofti and Onchocerca volvulus infection. Clin Vaccine Immunol. 2015;22:896\u2013901.","journal-title":"Clin Vaccine Immunol."},{"key":"3824_CR10","doi-asserted-by":"publisher","first-page":"e69231","DOI":"10.1371\/journal.pone.0069231","volume":"8","author":"A Golden","year":"2013","unstructured":"Golden A, Steel C, Yokobe L, Jackson E, Barney R, Kubofcik J, et al. Extended result reading window in lateral flow tests detecting exposure to Onchocerca volvulus: a new technology to improve epidemiological surveillance tools. PLoS One. 2013;8:e69231.","journal-title":"PLoS One."},{"key":"3824_CR11","doi-asserted-by":"publisher","first-page":"e0005314","DOI":"10.1371\/journal.pntd.0005314","volume":"11","author":"YL Lont","year":"2017","unstructured":"Lont YL, Coffeng LE, de Vlas SJ, Golden A, de Los Santos T, Domingo GJ, et al. Modelling Anti-Ov16 IgG4 antibody prevalence as an indicator for evaluation and decision making in onchocerciasis elimination programmes. PLoS Negl Trop Dis. 2017;11:e0005314.","journal-title":"PLoS Negl Trop Dis."},{"key":"3824_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.4269\/ajtmh.17-0756","volume":"98","author":"O Lagatie","year":"2018","unstructured":"Lagatie O, Verheyen A, Nijs E, Van Dorst B, Batsa Debrah L, Debrah A, et al. Evaluation of the diagnostic performance of Onchocerca volvulus linear epitopes in a peptide enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 2018;98:779\u201385.","journal-title":"Am J Trop Med Hyg."},{"key":"3824_CR13","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00436-019-06345-3","volume":"118","author":"O Lagatie","year":"2019","unstructured":"Lagatie O, Verheyen A, Nijs E, Batsa Debrah L, Debrah YA, Stuyver LJ. Performance evaluation of 3 serodiagnostic peptide epitopes and the derived multi-epitope peptide OvNMP-48 for detection of Onchocerca volvulus infection. Parasitol Res. 2019;118:2263\u201370.","journal-title":"Parasitol Res."},{"key":"3824_CR14","doi-asserted-by":"publisher","first-page":"e0005330","DOI":"10.1371\/journal.pntd.0005330","volume":"11","author":"O Lagatie","year":"2017","unstructured":"Lagatie O, Van Dorst B, Stuyver LJ. Identification of three immunodominant motifs with atypical isotype profile scattered over the Onchocerca volvulus proteome. PLoS Negl Trop Dis. 2017;11:e0005330.","journal-title":"PLoS Negl Trop Dis."},{"key":"3824_CR15","doi-asserted-by":"publisher","first-page":"e0004596","DOI":"10.1371\/journal.pntd.0004596","volume":"10","author":"E Granjon","year":"2016","unstructured":"Granjon E, Dichtel-Danjoy ML, Saba E, Sabino E, de Oliveira L, Zrein M. Development of a novel multiplex immunoassay multi-cruzi for the serological confirmation of chagas disease. PLoS Negl Trop Dis. 2016;10:e0004596.","journal-title":"PLoS Negl Trop Dis."},{"key":"3824_CR16","doi-asserted-by":"publisher","first-page":"e0006226","DOI":"10.1371\/journal.pntd.0006226","volume":"12","author":"M Zrein","year":"2018","unstructured":"Zrein M, Granjon E, Gueyffier L, Caillaudeau J, Liehl P, Pottel H, et al. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients. PLoS Negl Trop Dis. 2018;12:e0006226.","journal-title":"PLoS Negl Trop Dis."},{"key":"3824_CR17","doi-asserted-by":"publisher","first-page":"e12587","DOI":"10.1111\/pim.12587","volume":"40","author":"O Lagatie","year":"2018","unstructured":"Lagatie O, Verheyen A, Van Dorst B, Batsa Debrah L, Debrah A, Stuyver LJ. Linear epitopes in Onchocerca volvulus vaccine candidate proteins and excretory-secretory proteins. Parasite Immunol. 2018;40:e12587.","journal-title":"Parasite Immunol."},{"key":"3824_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13071-019-3308-z","volume":"12","author":"J Vlaminck","year":"2019","unstructured":"Vlaminck J, Lagatie O, Verheyen A, Dana D, Van Dorst B, Mekonnen Z, et al. Patent infections with soil-transmitted helminths and Schistosoma mansoni are not associated with increased prevalence of antibodies to the Onchocerca volvulus peptide epitopes OvMP-1 and OvMP-23. Parasit Vectors. 2019;12:63.","journal-title":"Parasit Vectors."},{"key":"3824_CR19","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1039\/C5LC00235D","volume":"15","author":"J Li","year":"2015","unstructured":"Li J, Rossignol F, Macdonald J. Inkjet printing for biosensor fabrication: combining chemistry and technology for advanced manufacturing. Lab Chip. 2015;15:2538\u201358.","journal-title":"Lab Chip."},{"key":"3824_CR20","first-page":"75","volume":"19","author":"MJ Mc","year":"1958","unstructured":"Mc MJ, Highton RB, Goiny H. The eradication of Simulium neavei from Kenya. Bull World Health Organ. 1958;19:75\u2013107.","journal-title":"Bull World Health Organ."},{"key":"3824_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1017\/S000748530003011X","volume":"37","author":"PC Garnham","year":"1947","unstructured":"Garnham PC, Mc MJ. The eradication of Simulium neavei Roubaud, from an onchocerciasis area in Kenya Colony. Bull Entomol Res. 1947;37:619\u201328.","journal-title":"Bull Entomol Res."},{"key":"3824_CR22","first-page":"195","volume":"37","author":"JM Roberts","year":"1967","unstructured":"Roberts JM, Neumann E, Gockel CW, Highton RB. Onchocerciasis in Kenya 9, 11 and 18 years after elimination of the vector. Bull World Health Organ. 1967;37:195\u2013212.","journal-title":"Bull World Health Organ."},{"key":"3824_CR23","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.pt.2012.04.005","volume":"28","author":"A Crump","year":"2012","unstructured":"Crump A, Morel CM, Omura S. The onchocerciasis chronicle: from the beginning to the end? Trends Parasitol. 2012;28:280\u20138.","journal-title":"Trends Parasitol."},{"key":"3824_CR24","first-page":"1","volume":"852","author":"WHO","year":"1995","unstructured":"WHO. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ Tech Rep Ser. 1995;852:1\u2013104.","journal-title":"World Health Organ Tech Rep Ser."},{"key":"3824_CR25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1186\/s13071-015-1166-x","volume":"8","author":"P Moraga","year":"2015","unstructured":"Moraga P, Cano J, Baggaley RF, Gyapong JO, Njenga SM, Nikolay B, et al. Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling. Parasit Vectors. 2015;8:560.","journal-title":"Parasit Vectors."},{"key":"3824_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/00034983.1964.11686225","volume":"58","author":"MJ Clarkson","year":"1964","unstructured":"Clarkson MJ. The species of Onchocerca in cattle in Kenya and Somalia. Ann Trop Med Parasitol. 1964;58:153\u20138.","journal-title":"Ann Trop Med Parasitol."},{"key":"3824_CR27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1017\/S0022149X00019453","volume":"36","author":"MC Round","year":"1962","unstructured":"Round MC. The helminth parasites of domesticated animals in Kenya. J Helminthol. 1962;36:375\u2013449.","journal-title":"J Helminthol."},{"key":"3824_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1128\/CMR.11.2.366","volume":"11","author":"TC Orihel","year":"1998","unstructured":"Orihel TC, Eberhard ML. Zoonotic filariasis. Clin Microbiol Rev. 1998;11:366\u201381.","journal-title":"Clin Microbiol Rev."},{"key":"3824_CR29","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1051\/parasite\/199401s1014","volume":"1","author":"B Hoch","year":"1994","unstructured":"Hoch B, Wahl G, Enyong P, L\u00fcder CG, Harnett W, Renz A. Onchocerciasis of cattle and man: serological recognition of parasite specific and cross-reactive antigens. Parasite. 1994;1:S14.","journal-title":"Parasite."},{"issue":"Suppl. 1","key":"3824_CR30","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1016\/j.actatropica.2010.01.014","volume":"120","author":"PE Simonsen","year":"2011","unstructured":"Simonsen PE, Onapa AW, Asio SM. Mansonella perstans filariasis in Africa. Acta Trop. 2011;120(Suppl. 1):S109\u201320.","journal-title":"Acta Trop."},{"key":"3824_CR31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4314\/ajid.v4i1.55085","volume":"4","author":"BL Downes","year":"2010","unstructured":"Downes BL, Jacobsen KH. A systematic review of the epidemiology of mansonelliasis. Afr J Infect Dis. 2010;4:7\u201314.","journal-title":"Afr J Infect Dis."},{"key":"3824_CR32","first-page":"9","volume":"9","author":"TH Ta-Tang","year":"2018","unstructured":"Ta-Tang TH, Crainey JL, Post RJ, Luz SL, Rubio JM. Mansonellosis: current perspectives. Res Rep Trop Med. 2018;9:9\u201324.","journal-title":"Res Rep Trop Med."},{"key":"3824_CR33","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.apjtm.2016.01.040","volume":"9","author":"JL Crainey","year":"2016","unstructured":"Crainey JL, da Silva TR, Luz SL. Historic accounts of Mansonella parasitaemias in the South Pacific and their relevance to lymphatic filariasis elimination efforts today. Asian Pac J Trop Med. 2016;9:205\u201310.","journal-title":"Asian Pac J Trop Med."},{"key":"3824_CR34","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1590\/0074-0276140079","volume":"109","author":"SL Luz","year":"2014","unstructured":"Luz SL, Crainey JL, Shelley AJ, Rubio M. Outstanding insecurities concerning the use of an Ov16-based ELISA in the Amazonia onchocerciasis focus. Mem Inst Oswaldo Cruz. 2014;109:506\u20138.","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"3824_CR35","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1179\/136485905X361990","volume":"99","author":"AW Onapa","year":"2005","unstructured":"Onapa AW, Simonsen PE, Baehr I, Pedersen EM. Rapid assessment of the geographical distribution of Mansonella perstans infections in Uganda, by screening schoolchildren for microfilariae. Ann Trop Med Parasitol. 2005;99:383\u201393.","journal-title":"Ann Trop Med Parasitol."},{"key":"3824_CR36","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13071-016-1960-0","volume":"10","author":"LB Debrah","year":"2017","unstructured":"Debrah LB, Nausch N, Opoku VS, Owusu W, Mubarik Y, Berko DA, et al. Epidemiology of Mansonella perstans in the middle belt of Ghana. Parasit Vectors. 2017;10:15.","journal-title":"Parasit Vectors."},{"key":"3824_CR37","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1186\/s13071-016-1595-1","volume":"9","author":"S Wanji","year":"2016","unstructured":"Wanji S, Tayong DB, Layland LE, Datchoua Poutcheu FR, Ndongmo WP, Kengne-Ouafo JA, et al. Update on the distribution of Mansonella perstans in the southern part of Cameroon: influence of ecological factors and mass drug administration with ivermectin. Parasit Vectors. 2016;9:311.","journal-title":"Parasit Vectors."},{"key":"3824_CR38","doi-asserted-by":"publisher","first-page":"e2288","DOI":"10.1371\/journal.pntd.0002288","volume":"7","author":"F Schar","year":"2013","unstructured":"Schar F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al. Strongyloides stercoralis: global distribution and risk factors. PLoS Negl Trop Dis. 2013;7:e2288.","journal-title":"PLoS Negl Trop Dis."},{"key":"3824_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1386207013331309","volume":"4","author":"S Deroo","year":"2001","unstructured":"Deroo S, Muller CP. Antigenic and immunogenic phage displayed mimotopes as substitute antigens: applications and limitations. Comb Chem High Throughput Screen. 2001;4:75\u2013110.","journal-title":"Comb Chem High Throughput Screen."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-019-3824-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3824-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T13:42:07Z","timestamp":1695476527000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3824-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3824"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3824-x","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"30 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All samples used in this study were de-identified before being provided and usage of these samples for research purposes was approved by an ethical committee or Institutional Review Board (IRB). For samples collected in Kenya, the study was approved by the KEMRI Scientific and Ethics Review Unit (SERU), Nairobi, Kenya (Protocol # KEMRI\/SERU\/CGHR\/102\/3554). Since all study participants were minors, informed consent forms were signed by parents\/guardians of the study participants, and verbal assents were obtained from all study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"OL and LJS are current employees of Janssen Pharmaceutica NV, a Johnson and Johnson Company, and may own stock or stock options in that company. EG and MZ are current employees of InfYnity Biomarkers. MRO declares that he has no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"570"}}